Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 2 Frequency (number and percent) of different comorbidities among 439 COVID-19 patients

From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt

Comorbidity

Number

% from cases with comorbidities

% from all cases

Diabetes mellitus

147

54.2

33.5

Cardiovascular diseases

187

69.0

42.6

 Hypertension

131 (70.0%)

63.4

39.2

 Ischemic heart disease

8 (4.3%)

3.0

1.8

 Hypertension and IHD

41 (21.9%)

15.1

9.3

 AF

4 (2.1%)

1.5

0.91

 Valvular disease

2 (1.1%)

0.7

0.46

 Congenital cyanotic heart disease

1 (0.53%)

0.37

0.23

Chronic pulmonary diseases

31

11.4

7.1

 COPD

12 (38.7%)

4.4

2.7

 Asthma

10 (32.3%)

3.7

2.2

 ILD

3 (9.7%)

1.1

0.68

 SRBD

3 (9.7%)

1.1

0.68

 Previous pulmonary embolism

2 (6.5%)

0.74

0.46

 Pleural effusion

1 (3.2%)

0.37

0.23

Neuropsychiatric diseases

31

11.4

7.1

 Old CVS

16 (51.6%)

5.9

3.6

 Brain tumors

4 (12.9%)

1.5

0.91

 Epilepsy

3 (9.7%)

1.1

0.68

 Parkinson’s disease dementia (PDD)

2 (6.5%)

0.74

0.46

 MS

2 (6.5%)

0.74

0.46

 Parkinson’s disease (PD)

1 (3.2%)

0.37

0.23

 Alzheimer’s dementia

1 (3.2%)

0.37

0.23

 MG

1 (3.2%)

0.37

0.23

 Brain abscess

1 (3.2%)

0.37

0.23

Kidney disease

21

7.7

4.8

 Chronic kidney disease

18 (85.7%)

6.6

4.1

 ESRF on RD

2 (9.5%)

0.74

0.46

 Renal transplant

1 (4.8%)

0.37

0.23

Liver Disease

15

5.5

3.4

 HCV

7 (46.7%)

2.6

1.6

 HCV with cirrhosis

5 (33.3%)

1.8

1.1

 Portal hypertension with bleeding varices

1 (6.7%)

0.37

0.23

 Autoimmune hepatitis

1 (6.7%)

0.37

0.23

 Liver transplant

1 (6.7%)

0.37

0.23

Metabolic and endocrinal diseases

10

3.7

2.3

 Hypothyroidism

8 (80%)

3.0

1.8

 Gout

2 (20%)

0.74

0.46

Autoimmune diseases

7

2.6

1.6

 SLE

3 (42.9%)

1.1

0.68

 RA

1 (14.3%)

0.37

0.23

 Autoimmune vasculitis

1 (14.3%)

0.37

0.23

 Behcet’s disease

1 (14.3%)

0.37

0.23

 Scleroderma

1 (14.3%)

0.37

0.23

Other conditions/risk factors

9

3.3

2.1

 Malignancya

3 (18.8%)

1.1

0.68

 Chronic bilateral LL ischemia

3 (18.8%)

1.1

0.68

 Pregnancy

3 (18.8%)

1.1

0.68

  1. aAcute leukemia, lymphoma and breast cancer on chemotherapy
  2. IHD: ischemic heart disease; AF: atrial fibrillation; COPD: chronic obstructive pulmonary disease; ILD: interstitial lung diseases; SRBD: sleep related breathing disorders; ESRF on RD: end stage renal failure on regular dialysis; CVS: cerebrovascular stroke; HCV: hepatitis C virus; HCV: hepatitis C virus; CVS: cerebrovascular stoke; MS: multiple sclerosis; MG: myasthenia gravis; SLE: systemic lupus erythematosus; RA: rheumatoid arthritis
Back to article page